Tallink Grupp
7.9.2026 16:00:00 CEST | Globenewswire | Press release
AS Tallink Grupp Managers’ Transactions - Enn Pant
AS Tallink Grupp Managers’ Transactions - Enn Pant
Person subject to the notification requirement
Name: Pant, Enn
Position: Chairman of the Supervisory Board
Issuer: AS Tallink Grupp
LEI: 529900QRMWAKKR3L9W75
Notification type: Initial Notification
Transaction date: 07.09.2026
Place of transaction: OTC
Instrument type: Share
ISIN: EE3100004466
Nature of the transaction: exercise of a stock option
(X) linked to stock option program
Transaction details:
(1): Volume: 300,000; Unit price: 0.47 EUR
Aggregated transactions:
(1): Volume: 300,000; Volume weighted average price: 0.47 EUR
Anneli Simm
Investor Relations Manager
AS Tallink Grupp
Sadama 5
10111 Tallinn
E-mail: Anneli.simm@tallink.ee
Phone: +372 56157170
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
TecDo Technology Co., Limited23.10.2026 18:37:22 CEST | Press release
TGC 2026: Tec-Do Launches Navos Pro for Results-Driven AI for Work
CGTN23.10.2026 18:17:10 CEST | Pressemeddelelse
CGTN: Hvad fortæller historien om 'Half a Quilt' (Et halvt vattæppe) os om Kinas nye lange march?
Genmab A/S23.10.2026 17:55:00 CEST | Press release
Genmab Announces Rinatabart Sesutecan (Rina-S®) Demonstrates Statistically Significant Improvement in Progression-Free Survival and Overall Survival in Patients with Platinum-Resistant Ovarian Cancer
Idorsia Pharmaceuticals Ltd23.10.2026 17:45:00 CEST | Press release
Idorsia presents outstanding results with daridorexant in children and adolescents with insomnia and an expanding body of evidence in adults at Sleep Europe 2026
Novartis Pharma AG23.10.2026 17:45:00 CEST | Press release
Novartis remibrutinib delivered comprehensive disease control in Phase III RMS trials, with proven, robust safety profile
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom